• LAST PRICE
    43.8500
  • TODAY'S CHANGE (%)
    Trending Up1.8400 (4.3799%)
  • Bid / Lots
    43.8100/ 1
  • Ask / Lots
    43.8900/ 2
  • Open / Previous Close
    42.9500 / 42.0100
  • Day Range
    Low 41.1400
    High 44.8500
  • 52 Week Range
    Low 17.7200
    High 47.9000
  • Volume
    508,667
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 42.01
TimeVolumeCYTK
09:32 ET2127842.46
09:34 ET549041.28
09:36 ET460241.34
09:38 ET661242.44
09:39 ET412842.505
09:41 ET516842.675
09:43 ET1479743.13
09:45 ET645642.87
09:48 ET244642.865
09:50 ET590042.69
09:52 ET904942.73
09:54 ET359042.97
09:56 ET301042.99
09:57 ET70042.76
09:59 ET30042.83
10:01 ET100042.47
10:03 ET50042.72
10:06 ET152543.05
10:08 ET185043.19
10:10 ET520043.6385
10:12 ET920043.8
10:14 ET516943.98
10:15 ET120044.09
10:17 ET1414244.45
10:19 ET840444.33
10:21 ET509844.32
10:24 ET340044.44
10:26 ET1441444.58
10:28 ET490544.75
10:30 ET1116844.735
10:32 ET849544.77
10:33 ET863244.75
10:35 ET584544.595
10:37 ET319544.22
10:39 ET536744.7
10:42 ET656544.68
10:44 ET772944.71
10:46 ET241144.6
10:48 ET178544.355
10:50 ET60044.49
10:51 ET50044.58
10:53 ET113444.48
10:55 ET447544.46
10:57 ET280044.37
11:00 ET305444.2991
11:02 ET120044.26
11:04 ET260644.21
11:06 ET123444.17
11:08 ET326743.9
11:09 ET174644.01
11:11 ET79844.17
11:13 ET164044.08
11:15 ET50044.01
11:18 ET256244.18
11:20 ET264544.24
11:22 ET90044.0576
11:24 ET399244.27
11:26 ET122144.28
11:27 ET120844.39
11:29 ET132944.4
11:31 ET278244.37
11:33 ET355644.26
11:36 ET230144.16
11:38 ET30044.23
11:40 ET860744.34
11:42 ET169944.4
11:44 ET20044.409
11:45 ET186744.4
11:47 ET115244.515
11:49 ET100044.46
11:51 ET220044.45
11:54 ET258444.43
11:56 ET140044.39
11:58 ET70044.48
12:00 ET248044.48
12:02 ET2103144.48
12:03 ET130044.6
12:05 ET169044.39
12:07 ET165344.1386
12:09 ET50044.08
12:12 ET44843.92
12:14 ET110043.87
12:16 ET80343.67
12:18 ET30043.75
12:20 ET544843.63
12:21 ET244043.72
12:23 ET255843.89
12:25 ET150343.85
12:27 ET56643.89
12:30 ET60043.92
12:34 ET10043.805
12:36 ET90043.82
12:38 ET159143.71
12:39 ET80043.69
12:41 ET40043.69
12:43 ET10043.713
12:45 ET40043.61
12:48 ET140043.68
12:50 ET30043.7
12:52 ET50043.59
12:54 ET80643.55
12:56 ET30043.46
12:57 ET195843.54
12:59 ET161343.48
01:01 ET387843.56
01:03 ET88643.53
01:06 ET10043.56
01:08 ET132543.68
01:10 ET30043.73
01:12 ET75043.82
01:17 ET239643.75
01:21 ET60043.66
01:24 ET80043.85
01:26 ET411243.85
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCYTK
Cytokinetics Inc
3.2B
-13.6x
---
United StatesNTLA
Intellia Therapeutics Inc
3.0B
-9.3x
---
United StatesVSBC
Vitaspring Biomedical Co. Ltd
3.1B
2,447.0x
---
United StatesMRTX
Mirati Therapeutics Inc
2.9B
-4.9x
---
United StatesARWR
Arrowhead Pharmaceuticals Inc
3.1B
-18.9x
---
United StatesCERE
Cerevel Therapeutics Holdings Inc
3.1B
-15.2x
---
As of 2022-05-16

Company Information

Cytokinetics, Incorporated is a late-stage biopharmaceutical company. It is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for debilitating diseases. It is developing small molecule drug candidates specifically engineered to impact muscle function and contractility. Its clinical-stage drug candidates are: omecamtiv mecarbil, a cardiac myosin activator for the treatment of heart failure with reduced ejection fraction (HFrEF); CK-136, a cardiac troponin activator for the treatment of heart failure and other diseases; reldesemtiv (CK-2127107), a fast skeletal muscle troponin activator (FSTA) for the treatment of people living with debilitating diseases and conditions associated with muscular weakness; aficamten (CK-274), a cardiac myosin inhibitor designed to reduce the hypercontractility that is associated with hypertrophic cardiomyopathy (HCM); and CK-3772271 (CK-271), a second novel cardiac myosin inhibitor.

Contact Information

Headquarters
350 OYSTER POINT BOULEVARD, .SOUTH SAN FRANCISCO, CA, United States 94080
Phone
650-624-3000
Fax
650-624-3010

Executives

Independent Chairman of the Board
John Henderson
President, Chief Executive Officer, Director
Robert Blum
Chief Financial Officer, Senior Vice President
Ching Jaw
Chief Human Resources and Administration Officer
David Cragg
Executive Vice President, Chief Commercial Officer
Andrew Callos

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$3.2B
Revenue (TTM)
$65.0M
Shares Outstanding
85.7M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.24
EPS
$-3.22
Book Value
$2.88
P/E Ratio
-13.6x
Price/Sales (TTM)
48.6
Price/Cash Flow (TTM)
---
Operating Margin
-347.93%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.